Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Puente Maestu (Madrid, Spain). Cost effectiveness of bronchial thermoplasty for treatment of severe asthma patients in spain. 2798

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcomes and micro-costing of bronchial thermoplasty in severe asthma in the UK Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Efficacy of the long-term therapy with simbicort in children with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005 Thermoplasty for severe asthma Source: ERS Skills Course 2016 Year: 2016 Clinical response of severe asthma patients following Bronchial Thermoplasty. Source: International Congress 2017 – To freeze or heat? Year: 2017 Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults Source: Eur Respir Rev 2014; 23: 510-518 Year: 2014 The effectiveness of seretide in children with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004 Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 424s Year: 2001 Cost-effectiveness of bronchial thermoplasty (BT) treatment relative to no BT treatment option for patients with severe asthma Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 The effectiveness of fluconazol application in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 543s Year: 2004 Cost effectiveness of omalizumab in Swedish asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006 Bronchial thermoplasty benefits patients following withdrawal of LABA therapy Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Evaluating the efficacy of omalizumab in severe persistent asthma patients Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 The usefulness of the impulse oscillometry for predicting the treatment outcomes of bronchial thermoplasty in patients with severe asthma. Source: International Congress 2018 – Asthma analysis Year: 2018 Efficacy of symbicort administration in patients with bronchial asthma Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Ceruloplasmine efficacy in patients with asthma exacerbations Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Cost-effectiveness of fluticasone/salmeterol inhaler in treatment of moderate and severe bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008